Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neuroblastoma 31Central Nervous System Neoplasms 25Astrocytoma 13Medulloblastoma 11Brain Neoplasms 10Testicular Neoplasms 9Sarcoma 8Testicular Germ Cell Tumor 7Teratoma 7Ovarian Neoplasms 7Oligodendroglioma 7Choroid Plexus Neoplasms 7Familial ependymoma 6Neuroectodermal Tumors, Primitive, Peripheral 5Gliosarcoma 5Glioblastoma 5Rhabdoid Tumor 4Retinoblastoma 4Glioma 4Ependymoma 4Wilms Tumor 3Ovarian Germ Cell Cancer 3Optic Nerve Glioma 3Lymphoma 3Kidney Neoplasms 3Head and Neck Neoplasms 3Carcinoma, Ovarian Epithelial 3Teratoma, Testicular 2Seminoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2

Interventions

thymoglobulin 1prednylidene 1deltacortene 1carmustine, poliferprosan 20 drug combination 1Prednisone 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Etoposide 1Cytarabine 1Carmustine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Autoimmune Diseases of the Nervous System × Peripheral Blood Stem Cell Transplantation × CNS × Clear all
NCT00716066 2026-02-27

Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases

Fred Hutchinson Cancer Center

Phase 2 Active not recruiting
53 enrolled
CNS

Rasmussen subacute encephalitis, Autoimmune Diseases, Myasthenia Gravis, Neuromyelitis Optica, Lambert-Eaton Myasthenic Syndrome, Stiff-Person Syndrome, Autoimmune Diseases of the Nervous System, Polyradiculoneuropathy, Chronic Inflammatory Demyelinating, Vasculitis, Central Nervous System, Opsoclonus-Myoclonus Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡